185 related articles for article (PubMed ID: 36347556)
1. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
[TBL] [Abstract][Full Text] [Related]
2. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
[TBL] [Abstract][Full Text] [Related]
5. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora.
Lim DG; Jung SI; Kim MS; Chung HS; Hwang EC; Kwon DD
Prostate Int; 2021 Sep; 9(3):163-168. PubMed ID: 34692590
[TBL] [Abstract][Full Text] [Related]
7. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
Krsakova E; Cermak A; Fedorko M
J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
13. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
14. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.
Kisa E; Altug MU; Gurbuz OA; Ozdemir H
Int Braz J Urol; 2017; 43(6):1068-1074. PubMed ID: 28727372
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
